RBC Capital analyst Brian Abrahams maintained a Hold rating on Incyte (INCY – Research Report) on January 21 and set a price target of $70.00.
Fintel reports that on January 22, 2025, RBC Capital downgraded their outlook for Intra-Cellular Therapies (NasdaqGS:ITCI) ...
RBC Capital Markets sustained their positive stance on GE Aerospace (NYSE:GE), reiterating an Outperform rating and a $200.00 ...
Financial writer discusses RBC Capital's bullish outlook on Carvana, citing upside potential in retail unit estimates and path to durable free cash flow.
RBC Capital analyst Ken Herbert downgraded V2X (VVX) to Sector Perform from Outperform with a price target of $58, down from $70. With the incoming Trump presidency, the government services sector ...
RBC Capital Markets has upgraded the Utilities sector to Overweight, naming it the top defensive sector, while downgrading Energy to Market Weight. The decision follows a survey of RBCs US analysts, ...
Investors in fertilizer equities can expect steady prices and good cash generation, according to analysts at RBC Capital ...
However, its 2025 costs and capital expenditure guidance exceeded analyst expectations as well as its own previous guidance. For full-year 2025, Hochschild expects capital expenditure between $197 ...
A small change in BBVA’s takeover offer for Banco Sabadell SA announced Thursday seems to be a correction of a previous ...
Each year, RBC supports thousands of students from different educational backgrounds in exploring various career paths within ...
RBC Capital Markets sized up Shopify Inc. (NYSE:SHOP) ahead of the company's Q4 earnings report due out in a few weeks. Analyst Paul Treiber said data from several third-party sources indicates ...